Request Deal Involvement
Roche to acquire Spark Therapeutics for $4.3bn.
Identify your role
Select the side you represented in this transaction, and provide your current job title.
Service Providers
financial advisors
Centerview Partners
legal advisors
Goodwin Procter
financial advisors
TD Cowen
legal advisors to financial advisors
Kirkland & Ellis
legal advisors to financial advisors
Shearman & Sterling
financial advisors
Citigroup
legal advisors
Davis Polk & Wardwell
or
Principals
target
SPARK THERAPEUTICS
bidder
ROCHE HOLDINGS AG
Principals or Service Provider not listed?Add missing Service Provider or Principal
Enter your Job Title on this deal
This title will appear on your profile next to this deal involvement.
To help us verify your involvement, please include links to any relevant publications that mention you or your company's role in this deal:
All rights reserved. Copyright © 2025 Datasite